NCT06334237

Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine

Exploring the Psychosomatic Factors Influencing and Moderating the Efficacy of Holistic Care and Personalized Treatment for Migraine Patients: A Prospective Longitudinal Observational Study
Changhua Christian Hospital·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Migraine
Drug/Device/Intervention
personalized treatment
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Changhua Christian Hospital
Location
Chang Hua, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Apr 15, 2024
End date
Feb 21, 2026
Enrollment
120 participants
Primary outcome

Migraine attack frequency,Migraine attack intensity,Migraine attack duration,Effectiveness of acute medication

Summary

This research project aims at exploring the psychosomatic factors that influence and moderate
 the efficacy of holistic care and personalized treatment for migraine patients. It is a
 prospective longitudinal observational study. The project's goal is to understand how
 physical, psychological, spiritual, and social factors affect the care and treatment outcomes
 for migraineurs. The study will include participants aged 18 to 65, who meet the
 International Headache Society's criteria for migraines. It will utilize a range of
 methodologies including questionnaires, interviews, and medical records to collect data on
 various factors like lifestyle, psychological state, and social support. The project will
 assess the effectiveness of treatments, compliance, and other outcomes such as emotional and
 sleep conditions.

ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06334237
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06334237 through Pure Global AI's free database. This phase not specified trial is sponsored by Changhua Christian Hospital and is currently Not yet recruiting. The study focuses on Migraine. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.